Skip to content

Featured Blog

“Why You Should Give a Damn about Your Vendor’s Culture”

We think we have something pretty special at Cadence that you may never see directly.  It is technically invisible and a little hard to describe, but we think it’s tangibly felt by all our clients.  What is it? It’s simply our internal culture.   Perhaps you are thinking,  “Sure, but why should I care about it?” I’ll give you 3 good reasons that impact you and the work you do everyday with a vendor.

Read The Featured Blog >>

“Expanded Approval for ZYTIGA® for the Treatment of Castration-sensitive Prostate Cancer”

On February 7th, the FDA expanded the approval of abiraterone acetate (ZYTIGA®) treatment to patients with high-risk castration sensitive prostate cancer [1]. Abiraterone acetate (AA), marketed by Janssen Biotech Inc., was previously approved in 2011 in combination with prednisone…


“Tisagenlecleucel for Patients with Relapsed or Refractory Large B-cell Lymphoma”

On May 1, 2018, the FDA granted approval to Novartis Pharmaceuticals Corp. to market KYMRIAH® (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (R/R LBCL), including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high grade B-cell lymphoma and DLBCL arising from follicular lymphoma…


See More Articles >>

Featured Case Studies

Click Here for Medical Communication Case Studies >>
Click Here for Market Research Case Studies >>
Click Here for Consulting Case Studies >>


Scientific Content – Featured White Paper

Our goal in designing the White Paper series is to help our clients receive real scientific value to their projects and get a taste of our medical writing expertise.

Click here for our latest white paper >>

Featured Client Feedback

“The clear reports with actionable recommendations that Cadence provides and their ability to quickly plan effective, streamlined meetings for us has made them an instrumental collaborator.”

Daniel P. Lundberg
Vice President, Marketing
Salix Pharmaceuticals, Inc.

“What I appreciate about Cadence are their ability to focus on details, respond quickly, their close relationship with key opinion leaders, and the ease with which they can accommodate last minute requests.”

Bing Yuan – Executive Director and Head, Life Cycle Strategy
Novartis Oncology

“You do an excellent job, provide an ‘A’ team quality experience, are highly professional and work seamlessly with our staff.”

Wendy Ashman – Director of Operations
Physicians Education Resource

See More Client Feedback >>